Humana expects the new clinic deal to sharply cut related liabilities and lower financing costs. A new derivative and BlackRock's return protections remain, but Humana expects liabilities to fall significantly.
Fewer clinic-related liabilities and lower financing costs should ease pressure on Humana's finances. The deal still creates a derivative and gives BlackRock minimum-return protections, but Humana expects liabilities to fall significantly. Humana kept its adjusted profit target at least $9 per share for 2026. Its reported profit figures may change as it finishes closing its accounts.
BlackRock-managed funds will take WCAS's stake and receive minimum-return protections, but the new deal has no put option for BlackRock. The filing gives no expected profit or cost details to show a clear change for BlackRock.
Follow Humana Inc. (HUM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HUM